• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis.

作者信息

Hreshchyshyn M M, Aron B S, Boronow R C, Franklin E W, Shingleton H M, Blessing J A

出版信息

Int J Radiat Oncol Biol Phys. 1979 Mar;5(3):317-22. doi: 10.1016/0360-3016(79)91209-4.

DOI:10.1016/0360-3016(79)91209-4
PMID:110744
Abstract
摘要

相似文献

1
Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis.
Int J Radiat Oncol Biol Phys. 1979 Mar;5(3):317-22. doi: 10.1016/0360-3016(79)91209-4.
2
Clinical research on the treatment of locally advanced lung cancer: final report of VALG Protocol 13 Limited.
Cancer. 1978 Sep;42(3):1129-34. doi: 10.1002/1097-0142(197809)42:3<1129::aid-cncr2820420315>3.0.co;2-f.
3
Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage IIIB cervical cancer.羟基脲联合盆腔放疗与安慰剂联合盆腔放疗用于非手术分期的IIIB期宫颈癌的疗效比较
J Surg Oncol. 1989 Oct;42(2):120-5. doi: 10.1002/jso.2930420211.
4
Hydroxyurea plus pelvic radiation versus placebo plus pelvic radiation in surgically staged stage IIIB cervical cancer.羟基脲联合盆腔放疗与安慰剂联合盆腔放疗用于手术分期为IIIB期宫颈癌的疗效比较
J Surg Oncol. 1987 Jun;35(2):129-34. doi: 10.1002/jso.2930350214.
5
Hydroxyurea (NSC-32065) with irradiation for cervical carcinoma--preliminary report.羟基脲（NSC - 32065）联合放疗治疗宫颈癌——初步报告
Cancer Chemother Rep. 1968 Sep;52(5):601-2.
6
Hydroxyurea as a radiation sensitizer in women with carcinoma of the uterine cervix.羟基脲作为子宫颈癌女性患者的放射增敏剂。
Am J Obstet Gynecol. 1977 Oct 15;129(4):379-83. doi: 10.1016/0002-9378(77)90580-4.
7
A randomized trial of hydroxyurea versus misonidazole adjunct to radiation therapy in carcinoma of the cervix. A preliminary report of a Gynecologic Oncology Group study.羟基脲与米索硝唑辅助放疗治疗宫颈癌的随机试验。妇科肿瘤学组研究的初步报告。
Am J Obstet Gynecol. 1988 Jul;159(1):87-94. doi: 10.1016/0002-9378(88)90499-1.
8
Survival of nonsurgically staged patients with negative lymphangiograms who had Stage IIB carcinoma of the cervix treated by pelvic radiation plus hydroxyurea.经盆腔放疗加羟基脲治疗的IIB期宫颈癌且淋巴管造影阴性的非手术分期患者的生存率。
Am J Obstet Gynecol. 1985 Apr 15;151(8):1006-8. doi: 10.1016/0002-9378(85)90370-9.
9
Hydroxyurea and radiation therapy in advanced cervical cancer.羟基脲与放射疗法治疗晚期宫颈癌
Am J Obstet Gynecol. 1974 Dec 1;120(7):969-72. doi: 10.1016/0002-9378(74)90347-0.
10
Adriamycin and hydroxyurea as radiopotentiators in the treatment of squamous cell carcinoma of the cervix implanted in nude mice: a preliminary report.阿霉素和羟基脲作为裸鼠移植宫颈癌放射增敏剂的初步报告
Gynecol Oncol. 1980 Apr;9(2):170-6. doi: 10.1016/0090-8258(80)90024-4.

引用本文的文献

1
Triapine Radiochemotherapy in Advanced Stage Cervical Cancer.三嗪在晚期宫颈癌中的放化疗
Front Oncol. 2018 May 7;8:149. doi: 10.3389/fonc.2018.00149. eCollection 2018.
2
Comparison of the efficacy among multiple chemotherapeutic interventions combined with radiation therapy for patients with cervix cancer after surgery: A network meta-analysis.手术后宫颈癌患者多种化疗干预联合放疗的疗效比较：一项网状Meta分析。
Oncotarget. 2017 Jul 25;8(30):49515-49533. doi: 10.18632/oncotarget.17259.
3
American Brachytherapy Task Group Report: A pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer.
美国近距离放射治疗任务组报告：宫颈癌高剂量率近距离放射治疗临床结果的汇总分析。
Brachytherapy. 2017 Jan-Feb;16(1):22-43. doi: 10.1016/j.brachy.2016.03.008.
4
Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement.酒精滥用会降低宫颈癌患者的盆腔控制能力和生存率：改善预后的生活方式干预机会。
Am J Clin Oncol. 2017 Oct;40(5):451-457. doi: 10.1097/COC.0000000000000187.
5
Molecular Strategies of Deoxynucleotide Triphosphate Supply Inhibition Used in the Treatment of Gynecologic Malignancies.用于治疗妇科恶性肿瘤的三磷酸脱氧核苷酸供应抑制的分子策略。
Gynecol Obstet (Sunnyvale). 2011 Dec 10;Suppl 4:001. doi: 10.4172/2161-0932.s4-001.
6
Radiochemotherapy plus 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in advanced-stage cervical and vaginal cancers.晚期宫颈癌和阴道癌的放化疗联合 3-氨基吡啶-2-甲酰腙硫代半卡巴腙（3-AP，NSC #663249）。
Gynecol Oncol. 2013 Jul;130(1):75-80. doi: 10.1016/j.ygyno.2013.04.019. Epub 2013 Apr 18.
7
Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.宫颈癌中核苷酸还原酶的表达：放射肿瘤学组转化科学分析。
Int J Gynecol Cancer. 2013 May;23(4):615-21. doi: 10.1097/IGC.0b013e31828b4eb5.
8
Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer.子宫颈癌和阴道癌的治疗机制
Oncol Hematol Rev. 2012 Spring;8(1):55-60.
9
Ribonucleotide reductase inhibitors: a new look at an old target for radiosensitization.核苷酸还原酶抑制剂：为放射增敏寻找新的作用靶点。
Front Oncol. 2012 Jan 4;1:56. doi: 10.3389/fonc.2011.00056. eCollection 2011.
10
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.核苷酸还原酶抑制恢复铂耐药卵巢癌对铂类药物的敏感性：一项妇科肿瘤学组研究。
J Transl Med. 2012 Apr 27;10:79. doi: 10.1186/1479-5876-10-79.